|
2023 Conference Publication Patient-based benefit-risk assessment of DMARDs in the treatment of rheumatoid arthritis at different stages of the disease journeyEl Masri, Hiba, Benham, Helen, McGuire, Treasure, Hollingworth, Samantha and Van Driel, Mieke (2023). Patient-based benefit-risk assessment of DMARDs in the treatment of rheumatoid arthritis at different stages of the disease journey. American College of Clinical Pharmacy Annual Meeting 2023, Dallas, TX United States, 11-14 November 2023. |
|
2023 Conference Publication Investigating the Natural Disaster Preparedness of Hospital Pharmacists Across Four Hospitals in AustraliaMcCourt, Elizabeth, Anderson, Amelia, Hollingworth, Samantha and Barras, Michael (2023). Investigating the Natural Disaster Preparedness of Hospital Pharmacists Across Four Hospitals in Australia. 22nd Congress on Disaster and Emergency Medicine, Killarney, Ireland, 9-12 May 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s1049023x23003035 |
|
2022 Conference Publication Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factorsAndric, Teodora , Winckel, Karl , Tanzer, Timothy David , Hollingworth, Samantha , Smith, Lesley , Isoardi, Katherine , Tan, Olivier and Siskind, Dan (2022). Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors. Griffith Medical Student Conference, Gold Coast, QLD, Australia, 8 September 2022. |
|
2021 Conference Publication Inaccurate QT interval estimation in people taking antipsychotics: are we contributing to misinformed treatment decisions?Andric, T., Winckel, K., Tanzer, T., Siskind, D., Hollingworth, S., Smith, L. and Isoardi, K. (2021). Inaccurate QT interval estimation in people taking antipsychotics: are we contributing to misinformed treatment decisions?. National Medicines Symposium, Online, 18 May 2021. |
|
2019 Conference Publication Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapyYu, Su-Yeon, McKavanagh, Dan, McPherson, Ian, Walpole, Euan, Hollingworth, Samantha and Atkinson, Victoria (2019). Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy. HOBOKEN: WILEY. |
|
2019 Conference Publication Real-world consumers’ questions and concerns on DMARDs: a retrospective analysis of calls to a medicine call centreEl Masri, Hiba, Hollingworth, Samantha, van Driel, Mieke, Benham, Helen and McGuire, Treasure (2019). Real-world consumers’ questions and concerns on DMARDs: a retrospective analysis of calls to a medicine call centre. Australasian Pharmaceutical Science Association Annual Conference, Melbourne, VIC Australia, 1-4 December 2019. |
|
2019 Conference Publication Reviewing the quality of trials of biologic disease modifying antirheumatic drugs supporting PBS listing from 2006 – 2018Meija, Abigail, McGuire, Treasure, van Driel, Mieke L. and Hollingworth, Samantha A. (2019). Reviewing the quality of trials of biologic disease modifying antirheumatic drugs supporting PBS listing from 2006 – 2018. Australasian Pharmaceutical Science Association Annual Conference, Melbourne, VIC Australia, 1-4 December 2019. |
|
2018 Conference Publication Cost saving with a GP-led integrated health service delivery model for complex chronic disease: an optimal Beacon practiceJackson, Claire, Luke, Connelly, Donald, Maria, Vaikuntam, Bharat, Hollingworth, Samantha and Russell, Anthony (2018). Cost saving with a GP-led integrated health service delivery model for complex chronic disease: an optimal Beacon practice. London, United Kingdom: Ubiquity Press. doi: 10.5334/ijic.s1025 |
|
2018 Conference Publication When medical evidence is not enough: reflection of the longitudinal impact of Women’s Health Initiative study on hormone therapy use in Australia.Natari, R. B., McGuire, Treasure M., Baker, P. J., Clavarino, A., Dingle, K. and Hollingworth, S. A. (2018). When medical evidence is not enough: reflection of the longitudinal impact of Women’s Health Initiative study on hormone therapy use in Australia. . 2018 Clinical and Public Health Symposium, Brisbane, QLD< Australia, 22-23 November 2018. |
|
2018 Conference Publication Evaluating healthcare interventions using Interrupted time series analysis: an example from the Women’s Health Initiative study describing its impact on hormone therapy use in AustraliaNatari, R., McGuire, T. M., Clavarino, A. M., Dingle, K. D. and Hollingworth, S. A. (2018). Evaluating healthcare interventions using Interrupted time series analysis: an example from the Women’s Health Initiative study describing its impact on hormone therapy use in Australia. Indonesia in an era of change Conference, Brisbane, QLD, Australia, 3-4 April 2018. |
|
2018 Conference Publication Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trialSiskind, D., Mayfield, K., Winckel, K., Hollingworth, S. and Kisely, S. (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial. SHPA MM2019, Brisbane, Australia, 22-25 November 2019. |
|
2018 Conference Publication Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trialSiskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial. 6th Biennial Conference of the Schizophrenia International Research Society (SIRS), Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby016.436 |
|
2018 Conference Publication Sustained impact of the Women’s Health Initiative study on hormone therapy use in Australia: an interrupted time series analysisNatari, R., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Sustained impact of the Women’s Health Initiative study on hormone therapy use in Australia: an interrupted time series analysis. 27th Federation of Asian Pharmaceutical Associations Congress, Manila, Phillipines, 24-27 October 2018. |
|
2018 Conference Publication Women’s Health Initiative study: its longitudinal impact on hormone and complementary therapy use for menopausal symptoms in AustraliaNatari, R., Baker, P., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Women’s Health Initiative study: its longitudinal impact on hormone and complementary therapy use for menopausal symptoms in Australia. PSA18, Sydney, Australia, 27-29 July 2018. |
|
2018 Conference Publication Longitudinal impact of the Women’s Health Initiative study on hormone and complementary therapy used for menopausal symptoms in AustraliaNatari, R., Baker, P., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Longitudinal impact of the Women’s Health Initiative study on hormone and complementary therapy used for menopausal symptoms in Australia. National Medicines Symposium 2018, Canberra, ACT, Australia, 30 May - 1 June 2018. |
|
2017 Conference Publication RCT of Exenatide for Clozapine-associated obesitySiskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2017). RCT of Exenatide for Clozapine-associated obesity. 16th International Congress on Schizophrenia Research (ICOSR), San Diego, CA, United States, 24-28 March 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sbx023.046 |
|
2017 Conference Publication What do women want to know about menopausal symptoms management: An Australian medicines call centre analysis.Natari, R. B., McGuire, T. M., Clavarino, A. M., Dingle, K. D. and Hollingworth, S. A. (2017). What do women want to know about menopausal symptoms management: An Australian medicines call centre analysis.. APSA-ASCEPT 2017 Joint Scientific Meeting, Brisbane Convention and Exhibition Centre, Brisbane, Australa, 5-8 December 2017. |
|
2017 Conference Publication Use of hormone therapy for menopause in Australia over two decades: does the change in evidence matter?Natari, R. B., McGuire, T. M., Clavarino, A. M., Dingle, K. D. and Hollingworth, S. A. (2017). Use of hormone therapy for menopause in Australia over two decades: does the change in evidence matter?. ACPE 2017, PACE, Brisbane, 29-31 October 2017. |
|
2017 Conference Publication The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: A systematic review of longitudinal studiesNatari, R. B., Clavarino, A. M., McGuire, T. M., Dingle, K. D. and Hollingworth, S. A. (2017). The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: A systematic review of longitudinal studies. 16th International Congress of the International Federation of Psychiatric Epidemiology, Melbourne Convention Centre Melbourne Australia, 17-20 October 2017. |
|
2017 Conference Publication What do consumers want to know about their medicines? Consumer queries compared to medicines use.McGuire, Treasure, Pache, David, Hollingworth, Samantha and van Driel, Mieke (2017). What do consumers want to know about their medicines? Consumer queries compared to medicines use.. ACPE 2017, PACE, Brisbane, 29-31 October 2017. |
